Stevanato Group (NYSE:STVN) Updates FY 2022 Earnings Guidance

Stevanato Group (NYSE:STVNGet Rating) issued an update on its FY 2022 earnings guidance on Thursday morning. The company provided earnings per share guidance of $0.54-$0.56 for the period. The company issued revenue guidance of $1.02 billion-$1.03 billion, compared to the consensus revenue estimate of $964.03 million. Stevanato Group also updated its FY22 guidance to 0.51-0.53 EPS.

Stevanato Group Price Performance

Stevanato Group stock traded down €0.05 ($0.05) during trading hours on Thursday, hitting €17.41 ($17.95). 290,800 shares of the company traded hands, compared to its average volume of 328,297. The firm has a market cap of $5.15 billion and a P/E ratio of 30.48. The company has a quick ratio of 2.01, a current ratio of 2.48 and a debt-to-equity ratio of 0.22. The firm’s 50-day simple moving average is €15.79 and its two-hundred day simple moving average is €16.66. Stevanato Group has a 1-year low of €13.35 ($13.76) and a 1-year high of €29.18 ($30.08).

Stevanato Group (NYSE:STVNGet Rating) last released its earnings results on Tuesday, May 10th. The company reported €0.12 ($0.12) EPS for the quarter, beating the consensus estimate of €0.11 ($0.11) by €0.01 ($0.01). The firm had revenue of €212.10 million for the quarter, compared to analysts’ expectations of €212.23 million. Stevanato Group had a net margin of 14.57% and a return on equity of 16.39%. Stevanato Group’s quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter last year, the company earned $0.13 EPS. As a group, analysts forecast that Stevanato Group will post 0.52 earnings per share for the current fiscal year.

Stevanato Group Dividend Announcement

The firm also recently disclosed a — dividend, which was paid on Wednesday, July 13th. Stockholders of record on Tuesday, June 14th were paid a $0.051 dividend. The ex-dividend date was Monday, June 13th. This represents a dividend yield of 0.4%.

Wall Street Analyst Weigh In

Separately, Wells Fargo & Company decreased their target price on shares of Stevanato Group from $21.00 to $19.00 and set an overweight rating for the company in a report on Monday, April 25th. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of Moderate Buy and an average target price of €25.21 ($25.99).

Hedge Funds Weigh In On Stevanato Group

A number of institutional investors and hedge funds have recently bought and sold shares of STVN. Bank of New York Mellon Corp increased its position in Stevanato Group by 11.4% during the first quarter. Bank of New York Mellon Corp now owns 46,717 shares of the company’s stock worth $940,000 after acquiring an additional 4,798 shares during the period. BlackRock Inc. boosted its stake in Stevanato Group by 3.6% during the first quarter. BlackRock Inc. now owns 263,364 shares of the company’s stock worth $5,299,000 after buying an additional 9,125 shares in the last quarter. Lazard Asset Management LLC boosted its stake in Stevanato Group by 3.4% during the first quarter. Lazard Asset Management LLC now owns 6,366,679 shares of the company’s stock worth $128,097,000 after buying an additional 210,007 shares in the last quarter. UBS Group AG boosted its stake in Stevanato Group by 79.9% during the first quarter. UBS Group AG now owns 1,799 shares of the company’s stock worth $36,000 after buying an additional 799 shares in the last quarter. Finally, Wellington Management Group LLP boosted its stake in Stevanato Group by 21.2% during the first quarter. Wellington Management Group LLP now owns 992,326 shares of the company’s stock worth $19,966,000 after buying an additional 173,332 shares in the last quarter. Institutional investors own 90.26% of the company’s stock.

About Stevanato Group

(Get Rating)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.

Further Reading

Earnings History and Estimates for Stevanato Group (NYSE:STVN)

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.